Literature DB >> 9413015

Relationship between binding affinity and functional activity of nociceptin/orphanin FQ.

I D Adapa1, L Toll.   

Abstract

The relationship between binding affinity and functional activity of nociceptin/orphanin FQ binding was studied in brain membranes, membranes of Chinese hamster ovary cells transfected with ORL1, and intact CHO-ORL1 cells. Binding affinities were compared with potency for the stimulation of [35S]GTP gamma S binding in cell membranes, and inhibition of forskolin-stimulated cAMP accumulation in intact cells. Binding was conducted with [3H]14-Tyr-nociceptin, and in brain or cell membranes the affinity was found to be 50-100 pM. The binding of [3H]14-Tyr-nociceptin was found to be regulated by Na+ and GTP, as expected for an opioid-like receptor. In intact cells, saturation produced a curvilinear Scatchard Plot. Non-linear analysis indicated two states of the receptor, with the vast majority of binding being to a low affinity state of approximately 8 nM. This low affinity component is consistent with the lower potency derived from the inhibition of cAMP accumulation, stimulation of [35S]GTP gamma S binding, and other functional assays.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413015     DOI: 10.1016/s0143-4179(97)90032-9

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  20 in total

1.  Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II.

Authors:  V Blair Journigan; Willma E Polgar; Taline V Khroyan; Nurulain T Zaveri
Journal:  Bioorg Med Chem       Date:  2014-03-05       Impact factor: 3.641

2.  Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists.

Authors:  Ludovico Arcuri; Salvatore Novello; Martina Frassineti; Daniela Mercatelli; Clarissa Anna Pisanò; Ilaria Morella; Stefania Fasano; Blair V Journigan; Michael E Meyer; Willma E Polgar; Riccardo Brambilla; Nurulain T Zaveri; Michele Morari
Journal:  Br J Pharmacol       Date:  2018-01-31       Impact factor: 8.739

3.  (8-Naphthalen-1-ylmethyl-4-oxo-1-phenyl-1,3,8-triaza-spiro[4. 5]dec-3-yl)-acetic acid methyl ester (NNC 63-0532) is a novel potent nociceptin receptor agonist.

Authors:  C Thomsen; R Hohlweg
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

4.  Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors.

Authors:  H Okawa; B Nicol; R Bigoni; R A Hirst; G Calo; R Guerrini; D J Rowbotham; D Smart; A T McKnight; D G Lambert
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

5.  Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro.

Authors:  S Werthwein; U Bauer; M Nakazi; M Kathmann; E Schlicker
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

6.  Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP receptor-selective scaffolds. Part I.

Authors:  Nurulain T Zaveri; Faming Jiang; Cris Olsen; Willma E Polgar; Lawrence Toll
Journal:  Bioorg Med Chem Lett       Date:  2013-04-04       Impact factor: 2.823

7.  In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations.

Authors:  Federica Ferrari; Maria Camilla Cerlesi; Davide Malfacini; Laila Asth; Elaine C Gavioli; Blair V Journigan; Uma Gayathri Kamakolanu; Michael E Meyer; Dennis Yasuda; Willma E Polgar; Anna Rizzi; Remo Guerrini; Chiara Ruzza; Nurulain T Zaveri; Girolamo Calo
Journal:  Eur J Pharmacol       Date:  2016-10-22       Impact factor: 4.432

8.  The design and synthesis of a novel quinolizidine template for potent opioid and opioid receptor-like (ORL1, NOP) receptor ligands.

Authors:  Ling Jong; Nurulain Zaveri; Lawrence Toll
Journal:  Bioorg Med Chem Lett       Date:  2004-01-05       Impact factor: 2.823

9.  Estrogen and progesterone modulate [35S]GTPgammaS binding to nociceptin receptors.

Authors:  Arnulfo Quesada; Paul Micevych
Journal:  Neuroendocrinology       Date:  2008-01-23       Impact factor: 4.914

10.  In vitro and ex vivo effects of a selective nociceptin/orphanin FQ (N/OFQ) peptide receptor antagonist, CompB, on specific binding of [3H]N/OFQ and [35S]GTPgammaS in rat brain and spinal cord.

Authors:  Shizuo Yamada; Toyofumi Kusaka; Akihiko Urayama; Ryohei Kimura; Yasuo Watanabe
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.